2013 (v1)
Publication
No description
Uploaded on: April 14, 2023
E
Last name: EMERY P
No description
Introduction: This 28-week, phase IIIb study assessed safety and maintenance of response to certolizumab pegol (CZP) in a diverse population of rheumatoid arthritis (RA) patients, stratified by prior anti-TNF exposure, concomitant methotrexate (MTX) use and disease duration. The ability to predict achievement of low disease activity (LDA) at...
No description
No description
No description
No description
No description